OVERVIEW

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including skin cancer, sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidisciplinary management of cancer patients. The course reviews key evidence that forms the basis for current clinical practice guidelines and trends in new approaches including radiopharmaceutical therapy. In addition, the course covers use of stereotactic, hypofractionated, and adaptive radiation therapy as indicated to improve outcomes for patients. It also provides contouring education for gynecologic, thoracic and genitourinary malignancies. Learning Objectives: Upon completion of this activity, participants should be able to do the following: Describe and implement the latest radiation therapy treatment recommendations for clinical scenarios commonly encountered in clinical practice. Safely utilize the latest radiation technologies to improve patient care. Describe the data and clinical use of protons and heavy ions in the management of patients. Appropriately and safely incorporate the treatment of oligometastases into clinical practice. Describe the management of benign diseases with radiation.

KEY DATES

Registrations Open
13 Nov, 2026
Registrations Open
Event Start Date
04 Jan, 2027
Event Start Date
Event End Date
14 Feb, 2029
Event End Date
Credits

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 23.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1: The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 23.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 23 AMA PRA Category 1
  • TARGET AUDIENCE

    Radiation OncologistsMedical PhysicistsPhysicianPrimary Clinicians

    SPECIALITIES

    Radiation OncologyOncologyDiagnostic Radiology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationTBD

    RELATED CONFERENCES & LIVE WEBINARS